Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shozo Nishida

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Clinical & Experimental Metastasis|July 20, 2007
The protein kinase C inhibitor, H7, inhibits tumor cell invasion and metastasis in mouse melanoma via suppression of ERK1/2Masanobu Tsubaki, Hiroshi Matsuoka, Chikako Yamamoto, et al.
Clinical and Experimental Pharmacology & Physiology|November 3, 2016
The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin-induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathwaysMasanobu Tsubaki, Daichiro Fujiwara, Tomoya Takeda, et al.
Clinical and Experimental Medicine|October 26, 2019
Inhibition of HSP90 overcomes melphalan resistance through downregulation of Src in multiple myeloma cellsMitsuki Tabata, Masanobu Tsubaki, Tomoya Takeda, et al.
Clinical & Experimental Metastasis|July 16, 2010
Nitrogen-containing bisphosphonate, YM529/ONO-5920, inhibits tumor metastasis in mouse melanoma through suppression of the Rho/ROCK pathwayYoshihiro Tanimori, Masanobu Tsubaki, Yuzuru Yamazoe, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|October 22, 2017
Rebamipide suppresses 5-fluorouracil-induced cell death via the activation of Akt/mTOR pathway and regulates the expression of Bcl-2 family proteinsMasanobu Tsubaki, Tomoya Takeda, Ryo-Ta Asano, et al.
Journal of Surgical Oncology|November 17, 2018
Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S-1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancerMasayuki Shinkai, Motohiro Imano, Yasutaka Chiba, et al.
International Journal of Molecular Sciences|October 29, 2020
The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal CellsMasanobu Tsubaki, Shiori Seki, Tomoya Takeda, et al.
European Journal of Pharmacology|March 4, 2021
Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutationYusuke Morii, Masanobu Tsubaki, Tomoya Takeda, et al.
Leukemia Research|July 24, 2012
Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cellsMasanobu Tsubaki, Takao Satou, Tatsuki Itoh, et al.
Journal of Surgical Oncology|June 11, 2015
A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa-positive gastric cancerYing-Feng Peng, Motohiro Imano, Tatsuki Itoh, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Clinical & Experimental Metastasis|July 20, 2007
The protein kinase C inhibitor, H7, inhibits tumor cell invasion and metastasis in mouse melanoma via suppression of ERK1/2Masanobu Tsubaki, Hiroshi Matsuoka, Chikako Yamamoto, et al.
Clinical and Experimental Pharmacology & Physiology|November 3, 2016
The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin-induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathwaysMasanobu Tsubaki, Daichiro Fujiwara, Tomoya Takeda, et al.
Clinical and Experimental Medicine|October 26, 2019
Inhibition of HSP90 overcomes melphalan resistance through downregulation of Src in multiple myeloma cellsMitsuki Tabata, Masanobu Tsubaki, Tomoya Takeda, et al.
Clinical & Experimental Metastasis|July 16, 2010
Nitrogen-containing bisphosphonate, YM529/ONO-5920, inhibits tumor metastasis in mouse melanoma through suppression of the Rho/ROCK pathwayYoshihiro Tanimori, Masanobu Tsubaki, Yuzuru Yamazoe, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|October 22, 2017
Rebamipide suppresses 5-fluorouracil-induced cell death via the activation of Akt/mTOR pathway and regulates the expression of Bcl-2 family proteinsMasanobu Tsubaki, Tomoya Takeda, Ryo-Ta Asano, et al.
Journal of Surgical Oncology|November 17, 2018
Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S-1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancerMasayuki Shinkai, Motohiro Imano, Yasutaka Chiba, et al.
International Journal of Molecular Sciences|October 29, 2020
The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal CellsMasanobu Tsubaki, Shiori Seki, Tomoya Takeda, et al.
European Journal of Pharmacology|March 4, 2021
Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutationYusuke Morii, Masanobu Tsubaki, Tomoya Takeda, et al.
Leukemia Research|July 24, 2012
Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cellsMasanobu Tsubaki, Takao Satou, Tatsuki Itoh, et al.
Journal of Surgical Oncology|June 11, 2015
A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa-positive gastric cancerYing-Feng Peng, Motohiro Imano, Tatsuki Itoh, et al.
Pageof 13